{"url_path":"/sec/wh/8-k/2026-05-18/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1722684/0001140361-26-021771-index.html","accession_number":"0001140361-26-021771","cik":"0001722684","ticker":"WH","issuer_name":"WYNDHAM HOTELS & RESORTS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1722684/0001140361-26-021771-index.html","primary_entity_key":"0001722684","primary_entity_name":"WYNDHAM HOTELS & RESORTS, INC."},"word_count":65,"has_tables":true,"body_markdown":"Item 8.01 Other Events\n\nOn May 18, 2026, Geoff Ballotti, President and Chief Executive Officer of Wyndham Hotels & Resorts, Inc., sent a message to all team members disclosing he will be\nundergoing treatment for Multiple Myeloma. During this time, he plans to continue working largely as normal. A copy of his message is attached to this Current Report on Form 8-K as Exhibit 99.1."}